'Genetic heterogeneity' in HER2/neu testing by fluorescence in situ hybridization: a study of 2,522 cases. | Mod Pathol;25(5): 683-8, 2012 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Virtual Health Library

United States - Mexico Border

Subject descriptor lookup Advanced Search

'Genetic heterogeneity' in HER2/neu testing by fluorescence in situ hybridization: a study of 2,522 cases.

Chang, Martin C; Malowany, Janet I; Mazurkiewicz, Julita; Wood, Martha.

Affiliation

Chang MC; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada. mchang2@mtsinai.on.ca

Mod Pathol ; 25(5): 683-8, 2012 May.

Article in En | MEDLINE | ID: mdl-22282306

Subject(s)

Adenocarcinoma/diagnosis; Breast Neoplasms/diagnosis; Receptor, ErbB-2/genetics; Adenocarcinoma/genetics; Breast Neoplasms/genetics; Female; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Prognosis

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Adenocarcinoma / Receptor, ErbB-2 Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Year: 2012 Type: Article

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Adenocarcinoma / Receptor, ErbB-2 Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Year: 2012 Type: Article